China's National Association of Financial Market Institutional Investors accepted the application of Shanghai Fosun Pharmaceutical (Group) (HKG:2196, SHA:600196) to issue bonds of up to 10 billion yuan, according to a Hong Kong Stock Exchange filing on Tuesday.
The bonds are medium-term bonds worth 4 billion yuan and super short-term bonds amounting to 6 billion yuan.
The issuance of both bonds is valid within two years. Bank of Shanghai (SHA:601229) and China Merchants Bank (HKG:3968, SHA:600036) will serve as the joint lead underwriters for the issuances, the pharmaceutical company said.
The company's Hong Kong shares fell less than 2% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。